Free Trial

Clene (CLNNW) Competitors

$0.04 -0.01 (-21.65%)
(As of 11/20/2024 ET)

CLNNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Clene stock or one of its competitors? The main competitors of Clene include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Clene vs.

180 Life Sciences (NASDAQ:ATNFW) and Clene (NASDAQ:CLNNW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, community ranking, media sentiment and institutional ownership.

180 Life Sciences and Clene both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
CleneN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Clene N/A N/A N/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Clene'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Clene Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Clene$442KN/AN/AN/AN/A

Summary

Clene beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLNNW vs. The Competition

MetricCleneBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$163.46M$5.09B$8.81B
Dividend YieldN/A3.50%5.04%4.07%
P/E RatioN/A329.4794.6014.18
Price / SalesN/A14,863.411,217.5288.10
Price / CashN/A11.6739.4936.27
Price / BookN/A7.056.956.35
Net IncomeN/A-$18.37M$118.83M$225.71M
7 Day PerformanceN/A0.19%-1.52%-0.32%
1 Month PerformanceN/A8.18%-3.39%1.76%
1 Year PerformanceN/A25.03%32.17%27.70%

Clene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLNNW
Clene
N/A$0.04
-21.6%
N/AN/A$0.00$442,000.000.00100
ATNFW
180 Life Sciences
N/A$0.01
-11.1%
N/A-25.0%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.04
-20.6%
N/A-71.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$3.11
-8.5%
N/A+105.3%$0.00$306.77M0.004Gap Down
ALVO
Alvotech
2.3037 of 5 stars
$12.30
-1.0%
$18.00
+46.3%
+35.9%$0.00$93.38M-6.711,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.08
flat
N/A+77.4%$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/A-23.6%$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.05
-11.7%
N/A+179.9%$0.00$35.24M0.0070Gap Down
BTMDW
biote
N/A$0.50
flat
N/AN/A$0.00$187.23M0.00N/A

Related Companies and Tools


This page (NASDAQ:CLNNW) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners